Spyre Therapeutics, Inc. - Common Stock (SYRE)
As of 2026-06-01, Spyre Therapeutics, Inc. - Common Stock (SYRE) scored 23/100 on Shishin's four-engine momentum model, flagged by the Suzaku engine. It has appeared in 4 daily scans since 2026-05-14. The figures below are a historical research profile — the composite score and the momentum, trend, and volatility indicators the engines observed — not investment advice.
This is a historical snapshot (data as of 2026-06-01). Shishin's live daily signals are published each morning on the rankings board.
SYRE's composite score has faded 47 points (from 70 to 23/100) across its recent scans — momentum-of-score is cooling.
What is SYRE's Shishin momentum score?
As of 2026-06-01, SYRE scores 23/100 on Shishin's four-engine composite, flagged by the Suzaku engine. The score blends momentum, trend, and volatility indicators on a 0–100 scale.
Is SYRE showing a momentum setup?
SYRE's current setup state is "OTHER." This describes what the engines observe in the chart structure — it is a data classification, not a recommendation to buy or sell.
Which Shishin engine flags SYRE?
Most recently the Suzaku engine. Each of the four guardians is tuned for a different market regime.
How often has SYRE appeared in Shishin scans?
SYRE has appeared in 4 daily scans since 2026-05-14. Recurring appearances indicate a persistent setup; one-off appearances are more transient.
How is the Shishin score calculated?
The composite is a weighted blend of momentum (multi-horizon returns), trend (moving-average stack, distance from MAs), and volatility/liquidity (ADR, ATR, dollar volume) indicators, scored per the engine active for the current market regime.
Research data, not investment advice. Shishin publishes what its systematic engines observe; it does not recommend buying or selling any security, and is not a registered investment adviser or broker-dealer. See our risk disclosure.